FSSAI has opened three cases against Nestle India over claims on NAN Excella and Lactogen Pro, and a biotin shortfall found in a separate follow-up formula. We explain why a baby cannot read a label, question a claim or choose another meal, making this one category where marketing and harm sit dangerously close.